Mirae Asset Global Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$117M Buy
926,242
+91,198
+11% +$12M 0.17% 82
2026
Q1
$116M Buy
835,044
+67,595
+9% +$9.47M 0.04% 56
2025
Q4
$94.2M Buy
767,449
+156,615
+26% +$19M 0.26% 68
2025
Q3
$67.8M Buy
610,834
+54,068
+10% +$6.15M 0.21% 84
2025
Q2
$61.7M Buy
556,766
+42,128
+8% +$4.48M 0.22% 90
2025
Q1
$57.5M Buy
514,638
+80,473
+19% +$8.3M 0.23% 86
2024
Q4
$40.7M Buy
434,165
+34,549
+9% +$3.11M 0.17% 106
2024
Q3
$33.4M Buy
399,616
+53,033
+15% +$4.05M 0.15% 117
2024
Q2
$23.9M Sell
346,583
-1,124,719
-76% -$75.1M 0.12% 139
2024
Q1
$116M Buy
1,471,302
+31,567
+2% +$2.43M 0.25% 72
2023
Q4
$117M Sell
1,439,735
-101,041
-7% -$7.86M 0.24% 86
2023
Q3
$115M Buy
1,540,776
+164,822
+12% +$12.7M 0.25% 78
2023
Q2
$106M Sell
1,375,954
-36,436
-3% -$2.91M 0.23% 82
2023
Q1
$117M Sell
1,412,390
-202,502
-13% -$16.8M 0.27% 65
2022
Q4
$139M Sell
1,614,892
-25,399
-2% -$2.01M 0.36% 45
2022
Q3
$101M Sell
1,640,291
-21,718
-1% -$1.37M 0.27% 62
2022
Q2
$103M Buy
1,662,009
+217,307
+15% +$13.5M 0.26% 64
2022
Q1
$85.9M Buy
1,444,702
+263,212
+22% +$16.8M 0.18% 118
2021
Q4
$85.8M Buy
1,181,490
+186,429
+19% +$12.8M 0.18% 113
2021
Q3
$69.5M Buy
995,061
+166,873
+20% +$11.7M 0.18% 132
2021
Q2
$57M Buy
828,188
+118,874
+17% +$7.94M 0.16% 161
2021
Q1
$45.8M Buy
709,314
+101,148
+17% +$6.52M 0.16% 178
2020
Q4
$35.4M Buy
608,166
+119,143
+24% +$7.19M 0.13% 186
2020
Q3
$30.9M Buy
489,023
+55,940
+13% +$3.88M 0.15% 153
2020
Q2
$33.3M Buy
433,083
+77,269
+22% +$5.92M 0.2% 116
2020
Q1
$26.6M Buy
355,814
+33,197
+10% +$2.29M 0.21% 100
2019
Q4
$21M Buy
322,617
+5,754
+2% +$375K 0.13% 191
2019
Q3
$20.1M Buy
316,863
+40,326
+15% +$2.64M 0.14% 176
2019
Q2
$18.7M Buy
276,537
+23,997
+10% +$1.58M 0.13% 187
2019
Q1
$16.3M Buy
252,540
+31,302
+14% +$2.08M 0.12% 185
2018
Q4
$13.8M Buy
221,238
+14,865
+7% +$1.04M 0.13% 182
2018
Q3
$15.9M Buy
206,373
+55,732
+37% +$4.21M 0.12% 178
2018
Q2
$10.6M Buy
150,641
+18,416
+14% +$1.3M 0.14% 102
2018
Q1
$9.97M Buy
132,225
+11,912
+10% +$947K 0.13% 108
2017
Q4
$8.62M Buy
120,313
+1,083
+0.9% +$82.2K 0.12% 123
2017
Q3
$9.66M Buy
119,230
+28,339
+31% +$2.17M 0.18% 103
2017
Q2
$6.43M Sell
90,891
-15,809
-15% -$1.05M 0.11% 130
2017
Q1
$7.25M Buy
106,700
+46,100
+76% +$3.24M 0.14% 116
2016
Q4
$4.34M Sell
60,600
-20,043
-25% -$1.49M 0.1% 154
2016
Q3
$6.38M Sell
80,643
-31,774
-28% -$2.58M 0.13% 112
2016
Q2
$9.38M Buy
112,417
+79,239
+239% +$7.03M 0.24% 79
2016
Q1
$3.05M Sell
33,178
-32,620
-50% -$2.94M 0.08% 174
2015
Q4
$6.66M Buy
65,798
+9,272
+16% +$965K 0.22% 96
2015
Q3
$5.55M Buy
56,526
+26,678
+89% +$2.96M 0.23% 98
2015
Q2
$3.5M Buy
29,848
+755
+3% +$82.5K 0.11% 139
2015
Q1
$2.85M Buy
29,093
+5,060
+21% +$514K 0.1% 157
2014
Q4
$2.27M Sell
24,033
-470,962
-95% -$48.7M 0.08% 158
2014
Q3
$52.7M Sell
494,995
-665,120
-57% -$65.1M 1.9% 15
2014
Q2
$96.2M Sell
1,160,115
-66,554
-5% -$5.18M 2.14% 17
2014
Q1
$86.9M Buy
1,226,669
+574,639
+88% +$45.1M 2.21% 15
2013
Q4
$49M Buy
652,030
+110,755
+20% +$7.71M 2.06% 12
2013
Q3
$34M Buy
541,275
+23,402
+5% +$1.4M 1.54% 19
2013
Q2
$26.6M Buy
+517,873
New +$27M 1.41% 20

Other funds holding GILD

Mirae Asset Global Investments's GILD Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Gilead Sciences (GILD) stake by 11% in Q2 2026, buying an estimated $12M and bringing the position to 926,242 shares worth $117M. The position accounts for 0.17% of the portfolio, ranked #82.

Mirae Asset Global Investments first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $139M in Q4 2022. 992 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Mirae Asset Global Investments held 926,242 shares of Gilead Sciences worth $117M as of Q2 2026.
  • Mirae Asset Global Investments bought 91,198 Gilead Sciences shares in Q2 2026, an estimated $12M.
  • Gilead Sciences made up 0.17% of Mirae Asset Global Investments's portfolio in Q2 2026, its #82 holding.
  • Mirae Asset Global Investments first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Mirae Asset Global Investments's Gilead Sciences position peaked at $139M in Q4 2022.
  • 992 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.